The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
Through the first four games of the season, Noah Laba has stood out for the New York Rangers. Laba’s impressive play unexpectedly became the headline at training camp, as a once-considered lock to ...
The New York Rangers’ most underrated prospect just might be center Noah Laba. The Rangers drafted Laba in the fourth round of the 2022 NHL Draft, and over the years, he’s risen up the team’s prospect ...
Laba logged just 2:34 of ice time before exiting the contest. He has notched six goals and 16 points in 53 games this season.
Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...
_ A phase II multi-dose study shows fast-acting and long-lasting efficacy of LAS100977, Almirall_s novel once-daily inhaled beta2 agonist (LABA), for the treatment of bronchoconstriction in asthmatic ...
Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education. Administrative ...
Please provide your email address to receive an email when new articles are posted on . Moving from a low-dose inhaled corticosteroid to a medium-dose inhaled corticosteroid plus a long-acting beta ...
A review of postmarket safety studies by the US Food and Drug Administration (FDA) has found no significant increase in risk for serious asthma-related outcomes when a long-acting β-agonist (LABA) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results